Doxepin (Low-Dose)


Tricyclic antidepressant / H1 antagonist

Abstract

At low doses, the compound shows selective H1 antihistamine activity; muscarinic, alpha-1 adrenergic, and serotonergic activities relevant at higher antidepressant doses are minimal. The H1-mediated sleep maintenance effect targets sleep continuity rather than sleep onset. Pharmacokinetics: plasma half-life 15 hours; CYP2D6 and CYP1A2 metabolism. Schedule status: prescription-only; not federally scheduled.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs